Sodium Chloride → Coumarin

HRID 271047

반응식

HRID 271047 반응식
C1N(CCO)CCN(CCS(O)(=O)=O)C1.[Na+].[Cl-].[Cl-].[Cl-].[Ca+2].CCC(COC(C(N(CC[NH+](C)C)C)=O)(C1C=CC=CC=1)C1C=CC=CC=1)CC.[Cl-].NCC(N1CCC[C@H]1C(N[C@H](C(O)=O)CCCCN)=O)=O.NC[C:74]1[C:75](=[O:84])[O:76][C:77]2[C:82]([CH:83]=1)=[CH:81][CH:80]=[CH:79][CH:78]=2>>[O:76]1[C:77]2[C:82](=[CH:81][CH:80]=[CH:79][CH:78]=2)[CH:83]=[CH:74][C:75]1=[O:84]

참가 물질

6

실험 절차

Identification of functional placental bikunin was achieved by measuring its ability to inhibit bovine trypsin and human plasma kallikrein. Trypsin inhibitory activity was performed in assay buffer (50 mM Hepes, pH 7.5, 0.1 M NaCl, 2.0 mM CaCl2, 0.1% Triton x-100) at room temperature in a 96-well microtiter plate (Perkin Elmer) using Gly-Pro-Lys-Aminomethylcoumarin as a substrate. The amount of coumarin produced by trypsin was determined by measuring the fluorescence (ex=370 nm, em=432 nm) on a Perkin-Elmer LS-50B fluorimeter equipped with a plate reader. Trypsin (23 μg in 100 μl buffer) was mixed with 20 μl of the sample to be tested and incubated for 10 minutes at 25° C. The reaction was started by the addition of 50 μl of the substrate GPK-AMC (33 μM final) in assay buffer. The fluorescence intensity was measured and the % inhibition for each fraction was determined by: % inhibition=100×[1−Fo/F1] where Fo is the fluorescence of the unknown and F1 is the fluorescence of the trypsin only control. Kallikrein inhibitory activity of the fractions was similarly measured using 7.0 nM kallikrein in assay buffer (50 mM Tris, pH 8.0, 50 mM NaCl, 0.1% triton x-100) and 66.0 μM Pro-Phe-Arg-AMC as a substrate. Determination of the In Vitro Specificity of Placental Bikunin

출처 및 근거

ORD 기록
ord-09dadc4027264a6e95c94a13bb306e67
출처 데이터셋
uspto-grants-2008_11
특허 번호
US07452859B2

연결된 노트

불러오는 중…